A growing body of evidence supports an important role of the transcription
factor cAMP responsive element binding protein (CREB) in mediating opioid-i
nduced changes in the cAMP pathway. Regulation of CREB and subsequent chang
es in gene expression may underlie some long-term cellular adaptations asso
ciated with the administration of opioid drugs. The effect of morphine on t
he level of the transcription factor CREB, as well as CREB phosphorylation,
was investigated in NG108-15 cells. Morphine and the delta-opioid receptor
agonist [(D)-Pen(2,5)]enkephalin (DPDPE) produced a dose-dependent increas
e in CREB phosphorylation. The effect was reversed by naloxone and naltrind
ole, respectively. The calmodulin antagonist N-(6-aminohexyl)-5-chloro-1-na
phthalenesulfonamide hydrochloride (W-7), the protein kinase inhibitor stau
rosporine, as well, as 1-(5-isoquinolinesulfonyl)-2-methylpiperazine dihydr
ochloride (H-7), an inhibitor of protein kinase C and cAMP-dependent protei
n kinase, but not N[2-(methylamino)ethyl]-5-isoquinolinesulfonamide dihydro
chloride (H-8), an inhibitor of cAMP- and cGMP-dependent protein kinase, bl
ocked the opioid-induced CREB phosphorylation. The obtained results suggest
that in the cells studied opioids affect, via the delta-opioid receptor, s
timulatory intracellular mediator systems involving Ca2+/calmodulin and the
protein kinase C pathway. (C) 2000 Elsevier Science B.V. All rights reserv
ed.